Eau Thermale Avène and Breast Cancer Alliance: A Meaningful Partnership
In a remarkable initiative aimed at significantly improving the lives of breast cancer patients,
Pierre Fabre Laboratories, the globally recognized second-largest dermo-cosmetics company, has deepened its collaboration with the
Breast Cancer Alliance (BCA). This October, which marks Breast Cancer Awareness Month, the Eau Thermale Avène brand underscores its commitment to patient care by providing comforting skincare solutions to those affected by this devastating illness.
Skincare Initiatives for Breast Cancer Patients
During October, Eau Thermale Avène will implement a unique donation program, directly benefiting breast cancer patients. For each purchase made via
aveneusa.com, the company pledges to donate a 1.3 fl. oz.
Cicalfate+ Restorative Protective Cream to patients in BCA’s hospital and support initiatives. This cream is particularly significant because patients undergoing treatments such as chemotherapy and radiation frequently experience severe skin sensitivities and reactions. The
Cicalfate+ product, enriched with a cutting-edge postbiotic ingredient known as
C+ Restore, has been clinically proven to soothe, hydrate, and restore damaged skin barriers, providing crucial relief during challenging times.
Lisa Morris, the
CEO and President of Pierre Fabre USA, emphasizes the importance of this partnership:
“Facing breast cancer is a fight where every moment matters. Our commitment is about making direct impact and providing patients with a solution that can help restore and soothe their skin. This partnership delivers comfort and care directly to those in need and we're proud to partner with BCA on this initiative.”
A Legacy of Support and Research
The BCA has been a beacon of support in advancing breast cancer care for nearly 30 years, focusing on groundbreaking research, surgical fellowships, and essential diagnostic screening. The collaboration with Pierre Fabre Laboratories illustrates a shared commitment to enhancing outcomes and quality of life for those battling breast cancer.
Beyond their collaborative efforts with BCA, Pierre Fabre Laboratories extends its global support to breast cancer initiatives that emphasize patient care, awareness, and research. A striking example is their ongoing initiative, **